Synonyms: Nubain®
nalbuphine is an approved drug (FDA (1979))
Compound class:
Synthetic organic
Comment: Nalbuphine is a semi-synthetic opioid drug that acts as a full agonist at the κ opioid receptor and a partial agonist at μ and δ opioid receptors. It is chemically related to the opioid antagonists, naloxone and naltrexone, and the potent opioid analgesic, oxymorphone.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
No information available. |
Summary of Clinical Use ![]() |
Used in pain relief. |
Mechanism Of Action and Pharmacodynamic Effects ![]() |
The principal mechanism of action of nalbuphine is likely due to its interactions with the opiate system in the CNS. |
External links ![]() |
For extended ADME data see the following: Drugs.com |